Avian flu threat revives antivirals

摘要

AS MORE cases of avian flu crop up across the globe,the very real threat of a flu pandemic is finally hitting home.Countries are scrambling to prepare for an outbreak,breathing new life into a class of antiviral drugs.Sales of Roches Tamiflu,which had been lackluster in recent years,are set to quadruple this year,and BioCryst Pharmaceuticals Inc.'s Peramivir is back in development after several years collecting dust.